BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

975 related articles for article (PubMed ID: 29463031)

  • 21. Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.
    Gocha AR; Nuovo G; Iwenofu OH; Groden J
    Am J Pathol; 2013 Jan; 182(1):41-8. PubMed ID: 23260199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative Lengthening of Telomeres in the Budding Yeast
    Cohn M; Andersson AK; Mateo RQ; Möller MC
    G3 (Bethesda); 2019 Oct; 9(10):3345-3358. PubMed ID: 31427453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
    Perrem K; Colgin LM; Neumann AA; Yeager TR; Reddel RR
    Mol Cell Biol; 2001 Jun; 21(12):3862-75. PubMed ID: 11359895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences.
    Yu Y; Katiyar SP; Sundar D; Kaul Z; Miyako E; Zhang Z; Kaul SC; Reddel RR; Wadhwa R
    Cell Death Dis; 2017 Apr; 8(4):e2755. PubMed ID: 28425984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.
    Plantinga MJ; Pascarelli KM; Merkel AS; Lazar AJ; von Mehren M; Lev D; Broccoli D
    Mol Cancer Res; 2013 Jun; 11(6):557-67. PubMed ID: 23505069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
    Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
    Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative lengthening of telomeres in cancer stem cells in vivo.
    Bojovic B; Booth RE; Jin Y; Zhou X; Crowe DL
    Oncogene; 2015 Jan; 34(5):611-20. PubMed ID: 24531712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X-rays Activate Telomeric Homologous Recombination Mediated Repair in Primary Cells.
    De Vitis M; Berardinelli F; Coluzzi E; Marinaccio J; O'Sullivan RJ; Sgura A
    Cells; 2019 Jul; 8(7):. PubMed ID: 31336873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
    Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
    Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperextended telomeres promote formation of C-circle DNA in telomerase positive human cells.
    Jones CY; Williams CL; Moreno SP; Morris DK; Mondello C; Karlseder J; Bertuch AA
    J Biol Chem; 2023 May; 299(5):104665. PubMed ID: 37003504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease mutant analysis identifies a new function of DAXX in telomerase regulation and telomere maintenance.
    Tang M; Li Y; Zhang Y; Chen Y; Huang W; Wang D; Zaug AJ; Liu D; Zhao Y; Cech TR; Ma W; Songyang Z
    J Cell Sci; 2015 Jan; 128(2):331-41. PubMed ID: 25416818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomeres and telomerase in sarcomas.
    Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
    Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Loss of
    Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
    Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
    Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
    Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX.
    Hu Y; Shi G; Zhang L; Li F; Jiang Y; Jiang S; Ma W; Zhao Y; Songyang Z; Huang J
    Sci Rep; 2016 Aug; 6():32280. PubMed ID: 27578458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
    Pompili L; Leonetti C; Biroccio A; Salvati E
    J Exp Clin Cancer Res; 2017 Dec; 36(1):189. PubMed ID: 29273061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
    Ohali A; Avigad S; Naumov I; Goshen Y; Ash S; Yaniv I
    Genes Chromosomes Cancer; 2008 Nov; 47(11):965-70. PubMed ID: 18663749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative lengthening of telomeres in mammalian cells.
    Henson JD; Neumann AA; Yeager TR; Reddel RR
    Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCGA Pan-Cancer Genomic Analysis of Alternative Lengthening of Telomeres (ALT) Related Genes.
    Armendáriz-Castillo I; López-Cortés A; García-Cárdenas J; Guevara-Ramírez P; Leone PE; Pérez-Villa A; Yumiceba V; Zambrano AK; Guerrero S; Paz-Y-Miño C
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32708340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.